General Cancer News
Top Stories
Protein That Cuts Malignancy Of Breast Cancer Discovered
POSTED: April 22, 2008Researchers have discovered a protein which can reduce the malignancy of breast cancer tumors and also predict whether the cancer will metastasize, according to a study published Monday. "This protein seems to be suppressing tumor growth," said study author Kent Hunter of the National Cancer Institute outside of Washington. In studies on mice and ...
Looping Genes May Hold A Key To Understanding Breast Cancer
POSTED: April 22, 2008Another piece of the puzzle that is breast cancer has been found by University of Queensland researchers. Dr Melissa Brown, from UQ's School of Molecular and Microbial Sciences, and her team have discovered how a particular gene associated with breast cancer behaves, which may lead to better testing for the debilitating disease. Dr Brown and Dr Ju...
New Tests OK'd For Colon Cancer / Experts Say That Some People Are Avoiding The More Invasive Forms Of Testing
POSTED: April 22, 2008The American Cancer Society and other health groups are recommending two tests they had not previously endorsed to prevent or detect colorectal cancer. The new policy is based on evidence that the tests work well enough to recommend and applies to all adults 50 and older and to some younger people with symptoms or risk factors for colon cance...
NCCN Updates non-Hodgkin's Lymphoma Guidelines
POSTED: April 22, 2008FORT WASHINGTON, Pa. -- The National Comprehensive Cancer Network (NCCN) announces several new updates to the NCCN Clinical Practice Guidelines in Oncology(TM) Non-Hodgkin's Lymphoma (NHL). These changes highlight leading developments in the treatment of NHL and represent the recognized standard for clinical care in oncology in both the communit...
An Apple A Day Can Keep Colon Cancer Away, German Researchers Say
POSTED: April 22, 2008Hamburg, Germany -- German scientists have found new proof of that old adage about an apple a day keeping the doctor away by showing the fruit helps reduce the incidence of colon cancer. German researchers led by Dr Dieter Schrenk found that apples and apple juice enhance biological mechanisms that produce anticarcinogenic compounds during th...
Potential Cancer Drug Does Well In Study
POSTED: April 22, 2008BIRMINGHAM, Ala. -- A U.S. university study suggests the drug triphendiol causes tumor cell death in pancreatic and bile duct cancer, as well as slowing tumor growth. The study by University of Alabama at Birmingham researchers led by Assistant Professor Ewan Tytler showed the drug also sensitizes tumors to chemotherapy treatments. Tytler ...
Drug Compound Leads To Death Of Ovarian Cancer Cells Resistant To Chemotherapy
POSTED: April 18, 2008New Haven, Conn. -- In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR. Gil Mor, M.D., associate professor in the Depar...
Study Reveals Why Cancer Cells Like Sugar
POSTED: April 18, 2008DURHAM, N.C. -- U.S. medical researchers say they've discovered why cancer cells like sugar so much -- a finding than might lead to better cancer treatments. Duke University School of Medicine Assistant Professor Jeffrey Rathmell and graduate student Jonathan Coloff found that tumor cells use glucose as a way to avoid programmed cell death. ...
New Regulatory Circuit Identified For Aggressive, Malignant Brain Tumor
POSTED: April 18, 2008Research using a newly developed algorithm has significantly advanced understanding of the molecular events associated with the most common primary brain tumor in adults, human glioblastoma (GBM). The research, published by Cell Press in the April issue of the journal Cancer Cell, validates known genetic aberrations and identifies events not previously ...
Secrets Of Cellular Signaling Shed Light On New Cancer Stem Cell Therapies
POSTED: April 18, 2008ANN ARBOR, Mich. -- By revealing the inner workings of a common cell-to-cell signaling system, University of Michigan biologists have uncovered new clues about mysterious and contentious creatures called cancer stem cells. The findings also have implications for a high-profile breast-cancer drug trial getting underway at the U-M Medical School and tw...
